Clinical trials: ICP, open to volunteers
Advanced Solid Tumor
Evaluation of ICP-B381 in Patients With Advanced Solid Tumors
To evaluate the safety, tolerability, efficacy and pharmacokinetic characteristics of ICP-B381 in the trial participants of advanced solid tumors
- Trial name
- NCT07901413
- Testing
- ICP-B381
- Where
- China
- Volunteers
- 348 people
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia
Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage
This is a two-component prospective study of adult aneurysmal subarachnoid hemorrhage (aSAH) patients admitted to the Neurosciences Intensive Care Unit (NSICU) at UT Southwestern Medical Center.
- Conditions
- Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia, Cerebral Vasospasm, Autonomic Nervous System Diseases
- Trial name
- NCT07577739
- Testing
- Right-Sided Cervical Sympathetic Block at C6, Transcutaneous Auricular Vagal Nerve Stimulation (taVNS)
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- University of Texas Southwestern Medical Center
Central Nervous System Infections
Effect of a Bundle of Interventions on the Outcomes of Patients With Intracranial Devices (ICP Monitor e EVD)
Non-randomized clinical trial conducted in the adult ICUs of Brazilian hospitals participating in the IMPACTO MR Platform, involving adult patients using an intracranial pressure monitoring catheter device or external ventricular…
- Trial name
- NCT06412549
- Testing
- Health care practices and routines
- Volunteers
- 1,300 people
- Sponsor
- Beneficência Portuguesa de São Paulo
Advanced Solid Tumor
Evaluation of ICP-B208 in Patients With Advanced Solid Tumors
To evaluate the safety, tolerability, efficacy and pharmacokinetic characteristics of ICP-B208 in the trial participants of unresectable advanced or metastatic solid tumors
- Trial name
- NCT07617493
- Testing
- ICP-B208
- Where
- 3 sites in China
- Volunteers
- 551 people
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
Cardiac Arrest
Monitoring and Optimization of Cerebral Perfusion Pressure in Post-cardiac Arrest Patients: a Pilot Study
The goal of this study is to establish the ICP and CPP monitoring process and analyze the results in post-arrest patients, to validate the correlation between direct and non-invasive ICP monitoring indicators, to establish a…
- Trial name
- NCT06601842
- Testing
- ICP monitoring
- Where
- Taiwan
- Volunteers
- 50 people
- Sponsor
- National Taiwan University Hospital
Diabetes in Children, Diabetes Type 1
Intelligent Care Platform - Quasi-Experimental Trial
This study will measure the implementation and effectiveness of an intervention, the use of a digital health tool, Haibu Diabetes, for the management of pediatric type 1 diabetes (T1D), on clinical outcomes.
- Trial name
- UBColumbia (NCT07712809)
- Testing
- Digital Diabetes Care Platform
- Where
- Canada
- Volunteers
- 80 people
- Sponsor
- University of British Columbia
Severe Traumatic Brain Injury, Intracranial Hypertension
External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial
The goal of this phase 1 randomized controlled safety and feasibility clinical trial are to determine the safety of external lumbar drainage (ELD) in select patients with severe Traumatic Brain Injury (TBI).
- Trial name
- ELASTIC (NCT05889650)
- Testing
- External Lumbar drainage
- Where
- 6 sites in United States
- Volunteers
- 30 people
- Sponsor
- Brain Trauma Foundation
Peri-implantitis
Titanium Particle Release Across Non-Surgical Peri-implantitis Therapies
This prospective, randomized, controlled, single-blind, in vivo clinical and laboratory study aims to quantitatively compare the clinical success and metal ion release associated with four different non-surgical decontamination…
- Trial name
- NCT07811921
- Testing
- Mechanical Debridement with Titanium Curettes, Mechanical Debridement with Plastic Curettes, 940 nm Diode Laser Decontamination
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Saglik Bilimleri Universitesi